We recently cloned monoclonal IgM autoantibodies which bind to epitopes of oxidized low-density lipoprotein (OxLDL) from apoE-deficient mice (EO– autoantibodies). We now demonstrate that those EO– autoantibodies that were originally selected for binding to copper-oxidized low-density lipoproteins (CuOx-LDL), also bound both to the oxidized protein and to the oxidized lipid moieties of CuOx-LDL. The same EO– autoantibodies showed specific binding to products of oxidized 1-palmitoyl-2-arachidonoyl-phosphatidylcholine (OxPAPC) and to the specific oxidized phospholipid, 1-palmitoyl-2-(5-oxovaleroyl)-phosphatidyl-choline (POVPC), whereas oxidation of fatty acids (linoleic or arachidonic acid) or cholesteryl esters (cholesteryl-oleate or cholesteryl-linoleate) did not yield any binding activity. Those EO– autoantibodies that bound to oxidized phospholipids (e.g., EO6) inhibited the binding and degradation of CuOx-LDL by mouse peritoneal macrophages up to 91%, whereas other IgM EO– autoantibodies, selected for binding to malondialdehyde (MDA)-LDL, had no influence on binding of either CuOx-LDL or MDA-LDL by macrophages. F(ab′)2 fragments of EO6 were equally effective as the intact EO6 in preventing the binding of CuOx-LDL by macrophages. The molar ratios of IgM to LDL needed to maximally inhibit the binding varied from ∼8 to 25 with different CuOx-LDL preparations. Finally, a POVPC–bovine serum albumin (BSA) adduct also inhibited CuOx-LDL uptake by macrophages. These data suggest that oxidized phospholipid epitopes, present either as lipids or as lipid-protein adducts, represent one class of ligands involved in the recognition of OxLDL by macrophages, and that apoE-deficient mice have IgM autoantibodies that can bind to these neoepitopes and inhibit OxLDL uptake.
Sohvi Hörkkö, David A. Bird, Elizabeth Miller, Hiroyuki Itabe, Norbert Leitinger, Ganesamoorthy Subbanagounder, Judith A. Berliner, Peter Friedman, Edward A. Dennis, Linda K. Curtiss, Wulf Palinski, Joseph L. Witztum
Title and authors | Publication | Year |
---|---|---|
IL-33 reduces the development of atherosclerosis
AM Miller, D Xu, DL Asquith, L Denby, Y Li, N Sattar, AH Baker, IB McInnes, FY Liew |
Journal of Experimental Medicine | 2008 |
Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice
ML Smook, M Leeuwen, P Heeringa, JG Damoiseaux, R Theunissen, MJ Daemen, E Lutgens, JW Tervaert |
Clinical & Experimental Immunology | 2008 |
Oxidation-specific epitopes are important targets of innate immunity
MY Chou, K Hartvigsen, LF Hansen, L Fogelstrand, PX Shaw, A Boullier, CJ Binder, JL Witztum |
Journal of Internal Medicine | 2008 |
Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients
GJ Silverman, R Srikrishnan, K Germar, CS Goodyear, KA Andrews, EM Ginzler, BP Tsao |
Clinical & Experimental Immunology | 2008 |
Plasma Interleukin-5 Levels Are Related to Antibodies Binding to Oxidized Low-Density Lipoprotein and to Decreased Subclinical Atherosclerosis
M Sämpi, O Ukkola, M Päivänsalo, YA Kesäniemi, CJ Binder, S Hörkkö |
Journal of the American College of Cardiology | 2008 |
Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes
KC Briley-Saebo, PX Shaw, WJ Mulder, SH Choi, E Vucic, JG Aguinaldo, JL Witztum, V Fuster, S Tsimikas, ZA Fayad |
Circulation | 2008 |
Lipid peroxidation and decomposition — Conflicting roles in plaque vulnerability and stability
S Parthasarathy, D Litvinov, K Selvarajan, M Garelnabi |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2008 |
Lipids in Health and Disease
PJ Quinn, X Wang |
Lipids in Health and Disease | 2008 |
Lipids in Health and Disease
PJ Quinn, X Wang |
Lipids in Health and Disease | 2008 |
Lipids in Health and Disease
PJ Quinn, X Wang |
Lipids in Health and Disease | 2008 |
Reviews of Physiology Biochemistry and Pharmacology
SG Amara, E Bamberg, B Fleischmann, T Gudermann, SC Hebert, R Jahn, WJ Lederer, R Lill, A Miyajima, S Offermanns, R Zechner |
Reviews of Physiology Biochemistry and Pharmacology | 2008 |
Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
DM Stafforini |
Cardiovascular Drugs and Therapy | 2008 |
Autoimmunity in atherosclerosis: a protective response losing control?
J Nilsson, GK Hansson |
Journal of Internal Medicine | 2008 |
The aldo-keto reductase superfamily and its role in drug metabolism and detoxification
OA Barski, SM Tipparaju, A Bhatnagar |
Drug Metabolism Reviews | 2008 |
Accelerated atherosclerosis in ApoE deficient lupus mouse models
Z Ma, A Choudhury, SA Kang, M Monestier, PL Cohen, RA Eisenberg |
Clinical Immunology | 2008 |
Autoantibody Response to Chromatographic Fractions from Oxidized LDL in Unstable Angina Patients and Healthy Controls
DF Ketelhuth, GC Tonini, MD Carvalho, RF Ramos, P Boschcov, M Gidlund |
Scandinavian Journal of Immunology | 2008 |
Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA)
L Garrido-Sánchez, E García-Fuentes, G Rojo-Martínez, F Cardona, F Soriguer, FJ Tinahones |
British Journal of Nutrition | 2008 |
Circulating oxidized lipoproteins and cardiovascular risk
H Itabe |
Current Cardiovascular Risk Reports | 2008 |
Oxidation of LDL and its clinical implication
E Matsuura, GR Hughes, MA Khamashta |
Autoimmunity Reviews | 2008 |
Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus
L Garrido-Sánchez, F Cardona, E García-Fuentes, G Rojo-Martínez, JM Gómez-Zumaquero, MJ Picón, F Soriguer, FJ Tinahones |
European Journal of Clinical Investigation | 2008 |
Oxidized Low-Density Lipoprotein Is Not Equal to Oxidative Stress
LJ van Tits, AF Stalenhoef |
The American Journal of Cardiology | 2008 |
Generation and Identification of Natural Monoclonal Antibodies Against Low-Density Lipoprotein
X Feng, R Xu, Y Gao, Z He, C Li, H Wang |
Hybridoma | 2008 |
In Vivo Markers of Oxidative Stress and Therapeutic Interventions
S Tsimikas |
The American Journal of Cardiology | 2008 |
The role of innate immunity in atherogenesis: Fig. 1
K Hartvigsen, MY Chou, LF Hansen, PX Shaw, S Tsimikas, CJ Binder, JL Witztum |
Journal of lipid research | 2008 |
Interaction of Cytochrome c with 1-Palmitoyl-2-azelaoyl- sn -glycero-3-phosphocholine: Evidence for Acyl Chain Reversal
JP Mattila, K Sabatini, PK Kinnunen |
Langmuir | 2008 |